Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for prevention of contrast-induced nephropathy in PCI candidates
IRCT2016111530905N1Phase 3Completed
- Sponsor
- Imam Hossein Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in contrast-induced nephropathy (CIN), sponsored by Imam Hossein Hospital. Started Jan 2014; status: completed.
02
Drugs
pentoxifylline
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT2016111530905N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016111530905N1.